1. Introduction {#s0005}
===============

Neurological disorders account for more than 6% of the global burden of diseases. More than 1% of all deaths and 28% of all disability-adjusted life years (DALY) is due to neurological disorders \[[@bb0005]\]. Low and middle-income countries (LMIC) bear the greater proportion of this burden \[[@bb0010]\],. This trend is on the increase \[[@bb0015]\] due to several factors such as improvement in maternal and child health, increasing age of populations, and newly recognized disorders of the nervous system \[[@bb0005]\]. As a result, the global prevalence of neurological disorders is projected to hit 14.7% by 2020 \[[@bb0005]\]. Ironically, neurological manpower is far from being adequate to manage the present burden, as well as the projected upsurge. With an average of 0.04 neurologists per 100,000 populations in Africa, there is a staggering inadequacy of skilled professionals to effectively tackle the wide spectrum of neurological diseases, and provide timely and efficient preventive, restorative and rehabilitative services \[[@bb0020]\].

The burden of disease analyses is useful for informing health policy. It helps in identifying not only the fatal but also the non-fatal outcomes for diseases generally and of neurological illnesses in particular. Empirical evidence in our environment shows that the demand for neurological services is increasing. The quest for rapid, quality and evidenced based therapeutic measures in addition to increasing health literacy seems to drive this pursuit \[[@bb0025]\]. Although in-patient and community pattern of neurological diorders in some regions of Tanzania have been previously descibed \[[@bb0030],[@bb0035]\], there is pacuity of data on out-patient spectrum of neurological diorders.Characterizing consultation pattern can reveal the uptake rate of available neurological services. Furthermore, it can enhance the evaluation of individualized therapy; promote appraisal of quality of care, \[[@bb0040]\] and provide data for strengthening neurology manpower, delivery and expansion of services \[[@bb0045]\].

This study aims to determine the spectrum of neurological disorders presenting to the adult neurology clinic of AKHD, Tanzania. The study also aims to determine the demographic distribution of the main subcategories of the neurological conditions.

2. Methods {#s0010}
==========

This study was a 2 years retrospective survey of out-patient adult neurological consultations at the AKHD, Tanzania. Dar es Salaam is the economic capital of Tanzania and boasts of a population of 4,364,541, according to the official 2012 census \[[@bb0050]\]. It lies on latitude 6° 48′ 0″ S, and longitude 39° 17′ 0″ E. Dar es Salaam is one of the fastest-growing cities in the world and attracts a multi-ethnic group of residents. The AKHD, a joint commission international accredited (JCIA) private not for profit institution of health, is one of the oldest private health establishments in the metropolis which provides multidisciplinary secondary and tertiary care to the population. It is a 150 bedded institution that also serves as the teaching facility for the nascent faculty of postgraduate medical education of the Aga Khan University (AKU), Dar es Salaam, Tanzania. The AKHD offers a continuum of care that is coordinated across its primary medical centres (PMCs) in the urban areas of Mbeya, Iringa, Dodoma, Morogoro, and Mwanza and the 18 outreach health centers (OHCs) in Tanzania with 12 0f them being in Dar es Salaam.

The neurology unit of the hospital provides both in-patient and out-patient neurological services to residents of Dar es Salaam and other regions of Tanzania. The neurology unit is supported by a new clinical neurophysiology laboratory established in 2017. The laboratory performs electroencephalography (EEG) - including prolonged and video EEGs, evoked potential studies (EPs), electrodiagnostic (EDx) studies and sleep studies (the sleep laboratory was established in 2019). Radiological support is provided by the radiology department (Headed by AJ) that is equipped with a 1.5Tesla magnetic resonance imaging (MRI) machine, a computerized tomography (CT) scan machine as well as ultrasound machines for vascular and nerve ultrasonography.

The cardiology unit and the pathology departments provide additional supports for diagnostic evaluation of patients. Genetic screening and autoantibodies assay are outsourced. We do not perform nerve biopsies. The neurology clinic is staffed with 1 full time neurologist (PBA) who had fellowship training in clinical neurophysiology. The in-house neurologist is supported by a visiting adult neurologist (EA) and another visiting pediatric neurologist. There is a neurosurgeon (MCM) in the hospital who is also supported by another visiting surgeon. The final neurological diagnoses were arrived at, based on the patient\'s primary presentation, neurological exam, and subsequent blood, cerebrospinal fluid (CSF), radiological, and/or neurophysiological studies. The scientific committee as well as the health research and ethics committee of AKHD and AKU Tanzania approved the study.

2.1. Data collection {#s0015}
--------------------

A 2 year medical records (January 1, 2018 to December 31, 2019) of all adult neurology clinic consultations at the AKHD was collected from the health information and statistics (HIS) departments of the hospital. The HIS department operates an electronic medical record therefore; it is easier to trace all new and follow up consultations. Additional records were sought from other departments such as the radiology, cardiac, pathology and neurophysiology units, if clinical consultations were insufficient. The extracted data were patient\'s age, gender, date of consultation, diagnosis, medications and other adjuvant therapies.

2.2. Categorization {#s0020}
-------------------

The identified cases were classified according to the international classifications of diseases version 11 (ICD11) and cases confirmed as neurological were further analyzed. We have chosen to use ICD11 classification since the WHO website has officially approved six ICD-11 linearization \[[@bb0055]\] of which neurology is one. According to the ICD11 classification, neurological cases are classified as follows \[[@bb0005]\] movement disorders, \[[@bb0010]\] disorders with neurocognitive impairment as a major feature, \[[@bb0015]\] multiple sclerosis or other white matter disorders, \[[@bb0020]\] epilepsy or seizures, \[[@bb0025]\] headache disorders, \[[@bb0030]\] cerebrovascular diseases, (7)spinal cord disorders excluding trauma, \[[@bb0040]\] motor neuron diseases or related disorders, \[[@bb0045]\] disorders of nerve root, plexus and peripheral nerves, \[[@bb0050]\] diseases of neuromuscular junction or muscles \[[@bb0055]\], cerebral palsy, \[[@bb0060]\] nutritional or toxic disorders of the nervous system, \[[@bb0065]\] diseases of cerebrospinal fluid pressure or flow, \[[@bb0070]\] disorders of autonomic nervous system, \[[@bb0075]\] human prion diseases, \[[@bb0080]\] disorders of consciousness, \[[@bb0085]\] other disorders of the nervous system and, \[[@bb0090]\] post procedural disorders of the nervous system.

2.3. Statistical analysis {#s0025}
-------------------------

Descriptive statistics was performed to determine the frequency of neurological disorders as well as gender and age distribution. Continuous variables were summarized as means (standard deviation) when data was normally distributed. Skewed data were summarized as median (interquartile range, IQR). Pearson chi square test was used to determine between group differences of categorical data. Means and medians were compared using either the student\'s *t*-test or Mann--Whitney\'s *U* test for paired comparisons. All statistical analyses were performed using SPSS version 22.0 (SPSS, Chicago, Illinois). A *P*-value \<0.05 was considered to be statistically significant.

3. Results {#s0030}
==========

3.1. Demography and frequency of classes of neurological disorders {#s0035}
------------------------------------------------------------------

One thousand, one hundred and eighty-six (1186) patients were seen during the period, with an overall median age (IQR) of 40 (32.0--53.0) years. There were 597 (50.4%) females and 588 (49.6%) males with median age (IQR) of 38 (30.0--52.0) and 42 (33.0--54.5) years respectively (*p* = 0.001). [Table 1](#t0005){ref-type="table"} shows the age distribution of the patients according to gender. Females within the age of 21--30 years were significantly more than males (*p* = 0.004), while males between the ages of 71--80 years were significantly more than females (*p* = 0.003). [Table 2](#t0010){ref-type="table"} shows the categories of neurological disorders according to ICD 11 Classification. During the period under review, we did not see disorders of \[[@bb0005]\] autonomic nervous system, \[[@bb0010]\] Human Prion diseases, and disorders of consciousness; hence, these disorders did not reflect on [Table 2](#t0010){ref-type="table"}*.* Other conditions not categorized under section 8 of ICD 11 classifications were included as disorders classified elsewhere.Table 1Age and gender distribution of the patientsTable 1Age distributionTotalMalesFemalesX^2^OR95% CIP value1,186 (100%)588 (100%)597 (100%)\< 20 years96 (8.1)42 (7.1)54 (9.0)1.461.290.85--1.970.22721--30 years157 (13.2)61 (10.4)96 (16.1)8.461.661.18--2.340.004\*31--40 years352 (29.7)168 (28.6)184 (30.8)0.751.120.87--1.430.38641--50 years235 (19.8)132 (22.4)103 (17.3)4.960.720.54--0.960.026\*51--60 years171 (14.4)85 (14.5)86 (14.4)0.000.990.72--1.380.99061--70 years84 (7.1)42 (7.1)42 (7.0)0.000.990.63--1.540.94971--80 years67 (5.7)45 (7.7)22 (3.7)8.700.460.27--0.780.003\*\>81 years23 (1.9)13 (2.2)10 (1.7)0.740.700.31--1.590.391[^1]Table 2Neurological Disorders according to ICD 11 Classification.Table 2ICD 11 classificationsFrequencyNeurological disordersMaleFemaleP valuen (%)n (%)n (%)n (%)Movement disorders43(3.6)Parkinson's disease5 (19.2)2 (11.8)0.259Parkinson's plus syndrome3 (11.5)1 (5.9)Drug induced Parkinsonism3 (11.5)0 (0.0)Essential tremor1 (3.8)4 (23.5)Other tremors1 (3.8)3 (17.6)Dystonia8 (30.1)4 (23.5)Others5 (19.2)3 (17.6)Total26 (100)17 (100)Disorders with neurocognitive impairment as a major feature41 (3.5)Alzheimer's disease3 (15.0)10 (47.6)0.018\*Vascular dementia12 (60.0)6 (28.6)Dementia with lewy bodies3 (15)2 (9.5)Normal pressure hydrocephalus2 (10.0)--Mild cognitive impairment, no dementia0 (0.0)3(14.3)Total20 (100)21(100)Multiple sclerosis and other white matter disorders4 (0.3)Neurosarcoidosis1 (100)---Multiple sclerosis--2 (66.6)Clinically isolated syndrome--1 (33.3)Total1 (100)3 (100)Epilepsy or seizures111(9.3)Epilepsy due to structural or metabolic condition26 (48.1)24 (42.1)0.545Genetic or presumed genetic condition25 (46.3)27 (47.4)Epileptic Encephalopathy2 (3.7)2 (3.5)Seizure due to acute causes03 (5.3)Single unprovoked seizures1 (1.9)1 (1.8)Total54 (100)57 (100)Headache disorders320 (27.0)Migraine54 (42.9)120 (61.9)\<0.001\*Tension type headache18 (14.3)40(20.6)Chronic daily headache7 (5.6)6(3.1)Trigeminal autonomic celphalagias6 (4.8)4(2.1)Cervicogenic headaches20 (15.9)19(9.8)Others21 (16.7)5(2.6)Total126 (100)194(100)Cerebrovascular disease106 (8.9)Ischaemic stroke63 (87.5)34(100)0.210Haemorrhagic stroke6 (8.3)-Subarachnoid haemorrhage1 (1.4)-Transient ischaemic attack2 (2.8)-Total72 (100)34 (100)Spinal cord disorders excluding trauma4 (0.3)Potts disease1 (50)0.306HTLV associated myelopathy1(50)--Compressive myelopathy from prolapsed disc1(50)--Transverse myelitis1 (50)Total2(100)2 (100)Motor neuron diseases or related disorders4 (0.3)Amyotrophic lateral sclerosis2(100)1 (50)0.248HIV associated motor neuron disease--1 (50)Total2 (100)2 (100)Disorders of nerve root, plexus or peripheral nerves278 (23.4)Cervical radiculopathy41 (27.0)29 (23.0)0.401Lumbar radiculopathy40 (26.3)38 (30.2)Cervical & lumbar polyradiculopathy2 (1.3)4 (3.2)Brachial plexopathy2 (1.3)-Mononeuropathy40 (26.3)39 (31.0)Polyneuropathy27 (17.8)16 (12.7)Total152 (100)126 (100)Disease of neuromuscular junction or muscles9(0.75)Myasthenia gravis3 (75.0)5 (100)0.236Duchene muscular dystrophy1 (25.0)--Total3 (100)5 (100)Cerebral palsy1 (0.08)--1 (100)--Nutritional or toxic disorders of the nervous system3 (0.25)Alcohol withdraw syndrome1 (50.0)--0.223Korsakoff syndrome1 (50.0)--Vitamin B 12 deficiency--1(100)Total3 (100)1(100)Disorders of cerebrospinal fluid pressure or flow2(0.16)Idiopathic intracranial hypertension--1(100)Arachnoid cyst1(100)--Total1 (100)1 (100)Post procedural disorders of the nervous system2 (0.16)Post dura puncture headache--2 (100)--Other conditions classified elsewhere258 (21.7)0.265Mental, behavioural or neurodevelopmental disorders58 (4.9)Anxiety and fear related disorders17 (13.8)16 (11.8)Functional neurological disorders10 (8.1)10 (7.4)Neurodevelopmental disorders3 (2.4)2 (1.5)Musculoskeletal disorders90 (7.5)Cervical and lumbar sprain and/or spasm40 (32.5)50 (37.0)Central nervous system (CNS) tumor6 (0.05)Meningioma, schwannoma, pituitary adenoma4 (3.2)2 (1.5)Central nervous system (CNS) infections9 (0.7)TB meningitis and Cryptococci meningitis1 (0.8)8 (5.9)Disorders of vestibular function24 (2.0)Benign positional vertigo and Meniere's disease14 (11.3)10 (7.4)Sleep and wake disorders9(0.7)Insomnia, sleep apnea & restless leg syndrome7 (5.7)2 (1.5)Fibromyalgia15(1.3)--6 (4.9)9 (6.6)Other painful conditions unspecified25 (2.1)--11 (8.9)14 (10.3)General medical conditions22(1.8)--10 (8.1)12 (8.9)Total123 (100)135 (100)Total1186 (100)

3.2. Headache disorders {#s0040}
-----------------------

Three hundred and twenty patients (27.0%) consulted the clinic for headache disorders. The mean age ± SD was 36.27 ± 12.27. There was no difference in age between the genders (*p* = 0.958). Migraine (54.2%), followed by tension type headache (18.1%), were the predominant primary headaches. Thirteen (4.0%) patients had chronic daily headache while 10 patients (3.1%) had trigeminal autonomic cephalagias (cluster headache, 6 (0.5%); paroxysmal hemicranias, 3(0.25%); cluster tic syndrome = 1 (0.008%). [Table 3](#t0015){ref-type="table"} shows the other types of headaches. Females were the predominant sufferer of headache disorders (*p* ≤0.001). [Fig. 1](#f0005){ref-type="fig"} shows age and gender distribution of headache disorders in this study. The modal age distribution for both genders was 31--40 years.Table 3More detailed diagnoses not reflected on [Table 2](#t0010){ref-type="table"}Table 3ICD 11 (n = frequency)Diagnosis (n)Movement disorders Parkinson's Plus syndrome (n = 4)Vascular parkinsonism (1), progressive supranuclear palsy (2),multiple system atrophy (1) Dystonia (n = 12)Hemifacial spasm (5),Meige syndrome (1),cervical dystonia (2),tardive dyskinesia (2), writer's cramp (1),generalized dystonia (1) Others (n = 8)Hereditary ataxia (1),myoclonus(3),Tremor-dystonia (1),suspected SCA (3)Disorders with neurocognitive impairment as a major feature Others (n = 3)Mild cognitive impairment, no dementia.Headache Trigeminal autonomic celphalagiasCluster headache (6), paroxysmal hemicranias(3), cluster --tic syndrome (1) Other headachesMedication overuse headache(1),nummular headache (1),sinus headache (7), post traumatic headache (12),primary stabbing headache (1),hypnic headache (1),TMJ subluxation (1), unclassified (2)Nerve root, plexus and nerves Mononeuropathy (n = 84)[a](#tf0005){ref-type="table-fn"}Bell's palsy(16), trigeminal neuralgia(18), numb cheek syndrome(1), optic neuropathy (1), peripheral Horner's syndrome (2) Intercostal neuralgia (4), carpal tunnel syndrome(15), ulnar neuropathy(16), radial neuropathy (2), femoral neuropathy (1), peroneal neuropathy(3),piriformis syndrome (1), sciatic neuropathy (1). Polyneuropathy (n = 43)Guillain Barré syndrome (4), CIDP (1), sensory polyneuropathy (30), sensory-motor polyneuropathy(3), small fiber neuropathy(5)[^2]Fig. 1Age and Gender distribution for Headache disorders.Fig. 1

3.3. Disorders of nerve root, plexus, and peripheral nerves {#s0045}
-----------------------------------------------------------

Of the 278 patients with mean ± SD of 46.15 ± 13.26 years belonging to this category, 154 (55.4%) had cervical, lumbar spondylotic radiculopathy or polyradiculopathy. Seventy-nine patients had mononeuropathy, while 43 patients had polyneuropathy, constituting 28.4% and 15.5%, respectively. There was no significant gender difference in this category (*p* = 0.401). [Fig. 4](#f0020){ref-type="fig"}. shows the age and gender distribution of the patients in this group. The females in this category had two modal age range; 31-40 years and 41--40 years. The modal age range for males was 41--50 years. Detailed diagnosis of the mononeuropathy and polyneuropathy subgroup is presented in [Table 3](#t0015){ref-type="table"}.

3.4. Epilepsy and seizures {#s0050}
--------------------------

Of the 111 patients in this group, 50 (45%) had epilepsy due to structural or metabolic conditions while 52(46.8%) had genetic/ presumed genetic epilepsy. Four patients (3.6%) had epileptic encephalopathy while 3 (2.7%) patients had seizures due to acute causes. Two cases (1.8%) of unprovoked seizures were seen. The median age (IQR) of patients in this group was 33.0 (20.0--49.0). There was no gender difference between males and females (*p* = 0.626). [Fig. 2](#f0010){ref-type="fig"} shows the age and gender distribution of epilepsy and seizure disorders. The modal age range of females was \<20 years, while males had a modal age range of 31--40 years.Fig. 2Age and gender distribution for Epilepsy and Seizures.Fig. 2

3.5. Cerebrovascular disease {#s0055}
----------------------------

One hundred and six (8.9%) patients with median age (IQR) of 57.0 (49.5--69.0), had cerebrovascular diseases. There was no gender no age difference between the genders (*p* = 0.782). All the patients had brain imaging (CT and/or MRI) as well as vascular imaging (CT angiography or MR angiography) hence, adjudication of stroke types, arterial territory, and aetiology was possible for all cases. Ischaemic stroke predominated this group at 91.5%. Intracranial haemorrhage (intracerebral and subarachnoid haemorrhage) was the diagnosis in 6.6% patient. There were 2(1.9%) cases of transient ischaemic attacks (TIA). Although a preponderance of male ischaemic stroke survivors was noted, there was no significant difference between the genders (*p* = 0.21). [Fig. 3](#f0015){ref-type="fig"} shows the age and gender distribution of patients with cerebrovascular disorders. The modal age range for both sexes was 51--60 years.Fig. 3Age and gender distribution for cerebrovascular diseases.Fig. 3Fig. 4Age and gender distribution for disorders of nerve roots, plexus and peripheral nerves.Fig. 4

3.6. Movement disorders {#s0060}
-----------------------

Forty-three cases (3.6%), with median age (IQR) of 52. 50 (34.0--65.75) had movement disorders. There was no difference in age between the genders (*p* = 1.0). Dystonia and Parkinson\'s disease were the most common conditions in this group at 27.9% and 16.3%, respectively. The median (IQR) of patients with Parkinsonian disorder was 62 (49--73), while that of the dystonia group was 40 (29--54.5). Focal and segmental dystonia made up more than 90% of the cohort with dystonia. There was no gender difference in this group (*p* = 0.259). [Table 3](#t0015){ref-type="table"} shows more detailed diagnoses of the other subcategories in this group.

3.7. Disorders with neurocognitive impairment as a major feature {#s0065}
----------------------------------------------------------------

Forty-one patients (3.5%) had neurocognitive disorders and vascular dementia was the most common condition in this category (43.9%). Alzheimer\'s disease (AD) was the next most common (31.7). The mean age (SD) of this cohort is 66.4(15.3), with an age range of 30--82. There was a significant gender difference in this category (*p* = 0.018); more females had Alzheimer\'s disease while more males had vascular dementia. There were 5 (12.2%) patients who had Dementia with lewy bodies (DLB) and 2 patients (4.9%) with normal pressure hydrocephalus. Mild cognitive impairment (MCI) was present in 3 (7.3%) patients.

3.8. Disease of neuromuscular junction or muscles {#s0070}
-------------------------------------------------

Nine patients (0.75%) belonged to this category. With 8 patients (0.67%) diagnosed with myasthenia gravis and 1(0.08%) case of Duchene muscular dystrophy. The median (IQR) of the patients with myasthenia gravis was 41.0(34.7--45.0) with a female: male ratio of 1:1. Of the myasthenia gravis cases, 2 were ocular myasthenia and 6 were generalized. The patient thought to be having Duchene muscular dystrophy declined genetic testing. However, his phenotypic features are no doubt in keeping with the disorder.

3.9. Multiple sclerosis (MS) and other white matter disorders {#s0075}
-------------------------------------------------------------

Four patients with mean age ± SD of 26.0 ± 8.41 belonged to this category. The male to female ratio in this category was 3:1. Two (0.17%) had MS (0.34%) and one (0.08) had a clinically isolated syndrome. These were all females. The male patient had neurosarcoidosis. This case was diagnosed from an outside facility. The patient was being followed up in our facility.

3.10. Other neurological conditions {#s0080}
-----------------------------------

As shown in [Table 2](#t0010){ref-type="table"}, other less frequent disorders included spinal cord disorders excluding trauma (0.3%), motor neuron diseases or related disorders (0.3%) and nutritional or toxic disorders of the nervous system (0.25%), disorders of cerebrospinal fluid pressure or flow (0.16) and post procedural disorders of the nervous system (0.16%).There was a case of spastic cerebral palsy (0.08%).

3.11. Other conditions classified elsewhere {#s0085}
-------------------------------------------

Aside from the core neurological disorders detailed above, other illnesses that were commonly encountered in the clinic are as summarized in [Table 2](#t0010){ref-type="table"}. Musculoskeletal diseases were quite prevalent in this group, as it accounted for 7.6% of cases. These cases mostly consist of cervical and lumbar sprain and/or spasm. The next most common group of conditions is disorders of mental, behavioral and neurodevelopmental disorders. Among this cohort, anxiety and fear related disorders made up 2.9%, followed by dissociative neurological symptom disorders (functional neurological disorders) at 1.7%. Other painful conditions made up 2.1%, while disorders of vestibular function constituted 2.0%. Sleep and wake disorders (0.7%), CNS tumor (0.5%), and CNS infections (0.7%) were other conditions encountered in this group.

4. Discussion {#s0090}
=============

This study has profiled the spectrum of out-patient neurological disorders encountered in an adult neurology clinic of a private academic hospital in Tanzania. In this cohort of 1186 patients, we noted that headache disorders; disorders of the nerve root, plexus and peripheral nerves, epilepsy and cerebrovascular diseases were the predominant illnesses for which neurological consultations were sought. These four groups of disorders accounted for close to 70% of all the cases. This pattern is not in contrast to what is obtainable in out-patient neurology clinics in high-income countries (HIC). In Europe, headache, epilepsy, functional or psychological disorders, neuromuscular and peripheral nerve disorders as well as MS and related diseases are the predominant out-patient neurological cases \[[@bb0060],[@bb0065],[@bb0070]\].

In Africa, Siddiqi et al. in Zambia, found that the pattern of out-patient neurological conditions was similar to what might be expected in HIC \[[@bb0075]\] and Tegueu et al. in Cameroun \[[@bb0080]\] noted the same. Extant literatures show that CNS infectious diseases, cerebrovascular disorders and epilepsy including febrile convulsions were dominant neurological diagnoses in sub-Saharan African; including previous studies from Tanzania \[[@bb0085],[@bb0090],[@bb0095],[@bb0030],[@bb0100]\]. It should be noted, however, that these studies were conducted majorly among in-patient admissions hence;, our comparison is somewhat cautious because acute neurological cases like stroke and CNS infections are more likely to be admission cases \[[@bb0075]\].. The above being said, our study almost mirrors the pattern in the community when compared to the prevalence study by Dewhurst et al. \[[@bb0035]\] among older people in northern Tanzania. Aside for the dominance of movement disorders in that survey; headache, neuropathies and stroke constituted the bulk of other neurological diseases. In contrast to our study, Sarfo et \[[@bb0010]\] in Ghana found stroke to be the principal out-patient neurological diagnosis, followed by epilepsy and movement disorders. Variation in the service organization, referral bias, and the type of health facilities (government vs. private) could be responsible for the dissimilarities, although this assumption could be termed a priori. Ours, being a private health institution, patients can request for neurological consultations without a referral from a primary care physician or other medical specialties.

Headache is the most frequent neurological diagnosis in this cohort. This finding is similar to patterns in other studies in HIC \[[@bb0060],[@bb0065],[@bb0070]\] and SSA \[[@bb0080]\].. The high proportion of headache disorders in our group may not be unrelated to the high prevalence of the major primary headache disorders in Tanzania \[[@bb0105],[@bb0110],[@bb0115],[@bb0120]\]. Migraine, Tension-type headache (TTH) and medication overuse headache (MOH) are the 3 headache disorders of public health importance but migraine is the most disabling. Migraine is the second cause of disability globally \[[@bb0125]\]. It is the first cause of disability in people below 50 years \[[@bb0130]\]. Migraine affects one in ten people worldwide indicating a recent rise \[[@bb0135]\]. and higher prevalence is found among females, students, and urban residents just like our study suggests \[[@bb0140]\]. Although efforts at lifting the burden of headache are being instituted and recognized on the global level \[ [@bb0145]\], similar efforts are not visible in LMIC, especially Africa. Advocacy work to mitigate the burden of headache disorders is hugely needed and it is recommended that these endeavors should be championed by patients and practitioners \[[@bb0145]\].

The global burden of stroke has been well described \[[@bb0150]\]. Within the combined burden of neurological disorders, cerebrovascular diseases as measured in the GBD 2010, contribute an enormous proportions of DALY \[[@bb0015]\] Among in-patients in sub-Saharan Africa, stroke is the leading cause of neurological admission \[[@bb0030],[@bb0155],[@bb0160]\]. However, in this out-patient cohort, it is the fourth most common condition; in agreement with other studies \[[@bb0075],[@bb0080]\] This pattern would not be said to reflect the prevalence of stroke in the community as Dar es Salaam has been known to have a high incidence of stroke \[[@bb0165]\]. The rising burden of stroke in Tanzania is well documented \[[@bb0170]\], our institution is stroke ready and has an approved stroke fast pathway for triaging acute stroke cases in the emergency room. Patients who qualified for intravenous thrombolysis are offered the service. Mechanical thrombectomy program is yet to begin. Cases of cerebral haemorrhage requiring surgical intervention are managed, discharged and followed up by the neurosurgical team. This could account for the low frequency of haemorrhagic stroke in our cohort. Although Sarfo et al. reported a higher proportion stroke in their out-patient facility, the modal age range of cerebrovascular disease in our study mirrors that in Kumasi \[[@bb0010]\]. The demographic, nutritional and epidemiological transition that is happening across LMIC is undoubtedly driving the incidence of cardiovascular risk such as metabolic syndrome, hypertension and diabetes. Staunching this trend with proven preventive measures is indeed obligatory.

Over 85% of people living with epilepsy are found in low- and middle-income countries, including sub-Saharan Africa \[[@bb0175]\]. Epilepsy accounted for 9.3% of all the cases seen during this period. This proportion is similar to the studies \[[@bb0010],[@bb0075],[@bb0080]\]. The aetiology of epilepsy in Africa has been well described \[[@bb0180]\]. In this cohort of patients with epilepsy secondary to structural or metabolic brain disorders, we found that stroke, CNS trauma, mesial temporal sclerosis, and atrophy/neurodegenerative disorders were responsible for most cases in the category. Aside infections, non --communicable diseases play a corresponding and significant role in the onset of epilepsy in SSA. This underscores the need to increase public awareness of preventive measures against conditions such as traumatic brain injury, stroke and dementia. Stoke advocacy and public education would need to be escalated as well. Stroke survivors are significantly at a high risk of seizures \[[@bb0185]\] hence prevention is key. In the same manner, perinatal issues need to be well communicated and emphasized to the public.

Parkinsonian disorders and dystonia are the leading movement disorders in this cohort. As already established, the Parkinsonian disorders are common in the elderly. We saw two patients with early-onset Parkinson\'s disease, but further exploration of genetic underpinning could not be performed. The dystonia group was younger, though focal dystonia; Hemifacial spasm in particular was the dominant type in this cohort. In larger neurology practice, cervical dystonia is the most frequent focal dystonia \[[@bb0190]\]. The effort by the MDS to improve the diagnosis and management, including training and education of healthcare workers, is yielding fruits in Africa \[[@bb0195]\]. The frequency of disorders of cognition was comparable to that of movement disorders in our study and Alzheimer\'s disease trailed vascular dementia in rate. The dominance of the female gender with AD in this cohort reflects the already established pattern. About two-thirds of patients with AD are women \[[@bb0200]\]. Sex and gender differences in risk factors, symptom presentation, mortality and treatment are significant contributors to this pattern. A focus on these differences will lead to improved care and treatment \[[@bb0205]\].

Disorders of the peripheral nerves form a substantial proportion of patients in our study, and it is similar to the survey by stone et al. \[[@bb0060]\] We have gone ahead to detail the spectrum of these disorders ([Table 3](#t0015){ref-type="table"}) and narrow down the diagnosis with electrophysiological data when available. The lead author\'s subspecialty interest is in the area of peripheral nerve disorders, and this bias could have influenced referrals. Vestibular disorders and mental health disorders, in particular, functional neurological disorders, are encountered frequently by neurologists. Our data supports this. Recent insights from brain imaging and neurophysiology studies are helping to differentiate functional and feigned symptoms. Although these patients would benefit from both psychiatrist and neurologist review, the pendulum is again swinging in the direction of neurologists as the physician to take responsibility for functional neurological disorders \[[@bb0210]\].

4.1. Study limitations {#s0095}
----------------------

Its retrospective observational single center design limits our study. Undoubtedly, the findings would not represent the pattern of neurological disorders in the general population. Furthermore, this study population is highly selective, consisting of middle and high-income earners who have good insurance coverage or can pay cash for their healthcare costs. The strength of our study lies however, in the ability to thoroughly investigate our patients aside from other clinical evaluations as neurology demands. The electronic record system also ensured complete data capturing. Certainly, diagnostic confidence and accuracy is high in this cohort.

5. Conclusion {#s0100}
=============

In this cohort of urban dwellers who accessed care in a private academic hospital, we noted that non-communicable diseases of headache, peripheral nervous disorders, epilepsy and stroke were the leading cause of neurological consultation. Efforts at mitigating the burden of these illnesses at the population level might stem the raging tide of non-communicable neurological disorders in our environment. Future expansion of neurology services should explore establishment of specialty clinics devout to specific conditions such as headache, neuromuscular, epilepsy and stroke.
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[^1]: X2 = Pearson chi square; OR = odd ratio; \* = significant value.

[^2]: 5 patients had concurrent ulnar neuropathy and carpal tunnel syndrome hence the higher frequency of mononeuropathy; GBS, Guillain--Barré syndrome; CIDP, Chronic inflammatory demyelinating polyneuropathy; SCA, spinocerebellar degeneration; TMJ, temporomandibular joint subluxation.
